Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biolargo Inc BLGO

Chemicals Specialty Chemicals
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company operates through six segments: ONM Environmental, Clyra Medical Technologies (Clyra Medical), BioLargo Engineering (BLEST), BioLargo Canada, Inc. (Canada), BioLargo Energy Technologies, Inc. (BETI), and BioLargo Equipment Solutions & Technologies, Inc. (BEST). ONM Environmental... see more

Recent & Breaking News (OTCQX:BLGO)

BioLargo Q1 2023 Earnings Results Webcast and Conference Call on Thursday, May 18, 2023 - 4:30 PM Eastern Time

Accesswire May 17, 2023

BioLargo to Present at the Sequire Investor Summit in Puerto Rico

GlobeNewswire April 24, 2023

BioLargo Annual Report Highlights 132% Annual Revenue Increase, Reduced Net Loss

Accesswire April 3, 2023

BioLargo, Inc. Discusses 125% Revenue Increase and Significance of Proposed EPA PFAS Regulations with The Stock Day Podcast

Newsfile March 29, 2023

BioLargo 2022 Annual Earnings Results Webcast and Conference Call on Monday, April 3, 2023 - 4:30 PM Eastern Time

Accesswire March 29, 2023

BioLargo Acquires Rights to Sodium-Sulfur Battery Energy Storage Technology

Accesswire March 22, 2023

BioLargo Continues Record Setting Revenue Growth

Accesswire March 20, 2023

BioLargo's PFAS Treatment Technology Meets EPA's Proposed New Drinking Water Standards

Accesswire March 16, 2023

BioLargo Subsidiary Clyra Medical Technologies Adds Two Medical Industry Veterans to its Board of Directors

Accesswire February 20, 2023

BioLargo, Inc. Discusses 125% Revenue Increase for 2022 with The Stock Day Podcast

Newsfile January 31, 2023

BioLargo to Appear on ClearThink IR's Virtual Live Event on Wednesday, January 25, 2023 at 12 Noon ET

Accesswire January 24, 2023

BioLargo Grew 2022 Revenue by More Than 125% Over the Prior Year

Accesswire January 9, 2023

BioLargo's Partner Ikigai Begins Sales of Pooph at Walmart

Accesswire November 22, 2022

BioLargo Achieves 111% Growth to a Record $1.5 Million Revenue for Third Quarter 2022

Accesswire November 15, 2022

BioLargo Q3 2022 Earnings Results Webcast and Conference Call on Wednesday, November 16, 2022 - 5 PM Eastern Time

Accesswire November 10, 2022

Results from BioLargo's 18-Month Municipal Wastewater Treatment Pilot in Montreal Presented at National Conference

Accesswire November 8, 2022

BioLargo Adds Linda Park and Christina Bray to Board of Directors

Accesswire November 3, 2022

BioLargo Sets Another New Quarterly Revenue Record

Accesswire October 26, 2022

BioLargo, Inc. Discusses Its PFAS Treatment Solution and Odor Control Technology with The Stock Day Podcast

Newsfile October 25, 2022

BioLargo Secures Product Recovery Management (PRM) as Channel Partner and Contract Manufacturer for BioLargo's Water Treatment Technologies

Accesswire October 6, 2022